Search Results 571-580 of 16091 for saffron dosage

  1. Publications - Sridhar Yaddanapudi, Ph.D. - Mayo Clinic

    Optimizing dose rate to minimize delivery time in proton pencil beam dose-driven continuous scanning. Med Phys. 2025 Sep; 52 (9):e18098. View PubMed; Liu C ...

  2. Study of BLU-667 in Patients with Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors - Mayo Clinic

    ... dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also ...

  3. Clinical trials - Oncology (Medical)

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

  4. A Study to Evaluate the Effectiveness, Safety, Pharmacokinetics and Pharmacodynamics of Idasanutlin Monotherapy in Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera - Mayo Clinic

    ... dosages and risks/benefits. In the later phase (phase 3), researchers study ... Resistance to HU is defined at a dose ≥ 2 g/day or a maximum tolerated dose < 2 g ...

  5. Clinical trials - Oncology (Medical)

    This phase I trial studies the best dose and side effects of recombinant vesicular stomatitis virus carrying the human NIS and IFN beta genes (VSV-hIFNbeta- ...

  6. Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides - Mayo Clinic

    ... dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also ...

  7. Hematology - Clinical trials

    ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...

  8. Obstetrics and Gynecology - Clinical trials

    ... dose (RP2D) 1.1.2 To evaluate the safety and tolerability of this combination in a dose expansion cohort in patients with uterine serous carcinoma. A ...

  9. Performance-enhancing drugs: Know the risks - Mayo Clinic

    Many athletes take anabolic steroids at doses that are too high. These doses are much higher than those that health care providers use for medical reasons.

  10. Breast Clinic - Clinical trials

    To determine the maximally tolerated dose (MTD) of intratumoral administration of an Edmonston strain measeles virus genetically engineered to express NAP ...